中医药防治糖尿病系统综述的文献质量评价

Quality Assessment of Systematic Reviews of TCM Prevention and Treatment for Diabetes

目的通过对中医药防治糖尿病系统综述文献的质量评价,了解我国中医药防治糖尿病的循证研究进展。方法检索中国生物医学文献数据库、中国期刊全文数据库中关于中医药防治糖尿病的系统综述研究文献,并根据Meta分析报告的国际标准——PRISMA中27项条目对纳入研究的文献进行质量评价。结果共纳入研究66篇文献,涉及疗效评价有55篇,中医辨证分型评价5篇,方法学评价6篇。所纳入文献中涉及糖尿病并发症的种类有11种。PRISMA27项条目中除"用PICOS形式说明研究目的"及"具体研究方案及注册信息"无文献涉及外,其他25条均有文献涉及。检索频度最高的中、英文数据库分别是中国生物医学文献数据库和PubMed/MEDLINE;46篇系统综述对纳入的研究进行了质量评价。结论我国中医药防治糖尿病领域对循证医学的认识及重视程度均有了很大提高,但在糖尿病循证医学研究文献整体中仍不占优势。

Objective To assess the quality of systematic reviews of TCM prevention and treatment for diabetes and find out the evidence-based research progress of TCM prevention and treatment for diabetes in China. Methods The literatures on systematic reviews of TCM prevention and treatment for diabetes were searched in Chinese Biomedical Literature Database （CBM） and China National Knowledge Internet （CNKI）. The quality was assessed according to the International Standard for Reporting of Meta-analysis-PRISMA Statement. Results There were 66 articles enrolled, 55 articles involved therapeutic effect evaluation, 5 articles involved syndrome differentiation and 6 articles involved methodological evaluation. There were 11 compli- cations involved. There was no article involved two items in 27 PRISMA items, i.e. Explaining the research objectives with PICOS form and Specific research programs and registration inform. The frequent Chinese and English database searched was CBM and PubMed/MEDLINE respectively. There were 46 articles included quality assessment. Conleusion The emphasis on evidence-based medicine has greatly improved in TCM prevention and treatment for diabetes, but evidence-based medical re- search literature is still insufficient.